The presence of an association between chronic hepatitis B virus (HBV) infection and fatty liver is controversial. We examined the association between HBV infection and the development of nonalcoholic fatty liver disease (NAFLD). We conducted a cohort study of 83,339 participants without NAFLD at baseline who underwent serologic testing for hepatitis B surface antigen (HBsAg) between 2002 and 2006 and were followed annually or biennially until December 2014. NAFLD was defined as the presence of ultrasonographic fatty liver in the absence of excessive alcohol use or other identifiable causes. We used a parametric Cox model to estimate adjusted hazard ratios with 95% confidence intervals of incident NAFLD. During 484,736.1 person-years of follow-up, 20,200 incident NAFLD cases were identified. In models adjusted for age, sex, year of visit, smoking status, alcohol intake, regular exercise, education level, and body mass index, the adjusted hazard ratio (95% confidence interval) for incident NAFLD comparing HBsAg-positive to HBsAg-negative participants was 0.83 (0.73-0.94). After introducing HBV infection and confounders (including homeostasis model assessment of insulin resistance and metabolic factors) as time-dependent exposures, the association between HBV infection and decreased risk of incident NAFLD was attenuated but persisted. These associations were consistently observed across clinically relevant, prespecified subgroups. Conclusion: In this large cohort of apparently healthy Korean adults, HBsAg seropositivity was associated with lower risk of developing NAFLD, indicating a possible effect of HBV infection on the pathogenesis of NAFLD development. (HEPATOLOGY 2017;65:828-835). N onalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide.
N onalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. (1, 2) Aside from its potential to progress to cirrhosis and hepatocellular carcinoma, NAFLD is an emerging risk factor in type 2 diabetes, cardiovascular disease, and all-cause mortality. (3, 4) Furthermore, NAFLD is considered to be a precursor of metabolic syndrome. (5, 6) Epidemiologic approaches to identifying possible risk factors of NAFLD are necessary in order to develop preventive strategies. A complex network of genetic, epigenetic, and environmental factors is involved in the development and progression of NAFLD (7) ; however, the pathogenesis and risk factors of NAFLD are still not fully understood.
Chronic hepatitis B virus (HBV) infection is a leading cause of cirrhosis and hepatocellular carcinoma worldwide and accounts for the majority of liverrelated morbidity and mortality, especially in developing countries. (8, 9) Recently, chronic HBV infection has been reported to be related to steatosis, though its association with fatty liver is still controversial. (10) A recent cross-sectional study of 33,439 Taiwanese subjects demonstrated an inverse association between HBV infection and prevalence of NAFLD. (11) Another study, using proton magnetic resonance spectroscopy, a reference standard that defines the status of fatty liver, also demonstrated a lower prevalence of fatty liver in HBV patients than in uninfected patients. (12) Abbreviations: aHR, adjusted hazard ratio; ALT, alanine aminotransferase; anti-HBc, antibody to hepatitis B core antigen; anti-HBs, antibody to hepatitis B surface antigen; BMI, body mass index; CI, confidence interval; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HDL-C, high-density lipoprotein-cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein-cholesterol; NAFLD, nonalcoholic fatty liver disease.
However, the study was limited in its ability to establish a temporal relation between HBV infection and NAFLD. No cohort study has evaluated the association between HBV infection and incident NAFLD among subjects free of NAFLD at baseline. Therefore, we examined the association between HBV infection and the development of NAFLD in a large cohort of apparently healthy men and women who participated in a health screening examination program.
Materials and Methods

STUDY SUBJECTS
The Kangbuk Samsung Health Study is a cohort study of participants 18 years or older who underwent comprehensive health examinations at Kangbuk Samsung Hospital in Seoul, Korea. (13) Regular health screening exams are mandated for employees by the South Korea Industrial Safety and Health Law. Over 80% of participants in the study were employees in a company that contracted the routine health screening exams with the Kangbuk Samsung Hospital or their spouses. The rest of the participants voluntarily purchased health screening exams on their own. Abdominal ultrasounds are widely measured as a routine part of comprehensive health examinations in Korea. (14) The present analysis included all study participants with at least one follow-up visit who underwent serologic testing for hepatitis B surface antigen (HBsAg) between 2002 and 2006 and were followed annually or biannually until December 2014 (n 5 125,213). For the present cohort study, 41,874 were excluded at baseline for the following reasons: missing data on abdominal ultrasonography or serologic tests for HBsAg (n 5 4,348); fatty liver on baseline ultrasound (n 5 31,578); history of malignancy (n 5 747); significant alcohol consumption defined by alcohol intake 30 g/day for men and 20 g/day for women (n 5 9,591) according to the American Association for the Study of Liver Diseases practice guideline (1) ; and positive serologic marker of hepatitis C virus, history of cirrhosis, and use of medication associated with NAFLD within the past year, including amiodarone, tamoxifen, methotrexate, or corticosteroids (n 5 353).
(1) Because some individuals met more than one exclusion criterion, the total number of patients eligible for the study was 83,339. This study was approved by the institutional review board of Kangbuk Samsung Hospital, and the requirement for informed consent was waived because we used deidentified retrospective data routinely collected during the health screening process.
MEASUREMENTS
Data regarding medical history, medication use, family history, physical activity, alcohol consumption, smoking habits, and sociodemographic characteristics were collected through a standardized, selfadministered questionnaire, where anthropometric parameters and blood pressure were measured by trained staff during the health examination. (15) Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared.
Blood specimens were sampled from the antecubital vein after at least 10 hours of fasting. The presence of HBsAg, antibody to hepatitis B surface antigen (antiHBs), and antibody to hepatitis B core antigen (antiHBc) was determined using immunoradiometric assays (Radim, Via del Mare, Italy). infection. (16, 17) The HBsAg-negative participants were defined as healthy controls.
Measurements of serum biochemical parameters, including serum concentration of glucose, total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and serum high-sensitivity C-reactive protein have been described in detail elsewhere. (15) Abdominal ultrasounds were performed by experienced radiologists who were unaware of the aims of the study. An ultrasonographic diagnosis of fatty liver was defined as the presence of a diffuse increase in fine echoes in the liver parenchyma compared with kidney or spleen parenchyma. (19) NAFLD was defined as the presence of fatty liver in the absence of excessive alcohol use or other identifiable causes, as described in the exclusion criteria.
(1) The interobserver and intraobserver reliability values for the diagnosis of fatty liver were very high (kappa statistics of 0.74 and 0.94, respectively). (14) As described in the exclusion criteria, we had already excluded participants with excessive alcohol use (20 g/day for women and 30 g/day for men) (1) as well as other identifiable causes of fatty liver and, according to the practice guideline for the diagnosis and management of NAFLD, HBV infection was not considered the cause for secondary steatosis, unlike HCV genotype 3 infection (1) ; thus, incident cases of fatty liver were considered NAFLD.
STATISTICAL ANALYSES
Descriptive statistics were used to summarize the characteristics of the study participants according to the presence of HBsAg. The primary endpoint was development of NAFLD. Follow-up for each participant extended from the baseline exam until either the development of fatty liver or the last health exam conducted prior to December 31, 2014. Incidence rate was calculated as the number of incident cases divided by person-years of follow-up. Because we knew that fatty liver had occurred at some point between the two visits but did not know the precise timing of development, we used a parametric Cox model to account for this type of interval censoring (stpm command in Stata). (20) In these models, the baseline hazard function was parameterized with restricted cubic splines in log time with 4 degrees of freedom. We estimated the adjusted hazard ratio (aHR) with 95% confidence interval (CI) for incident NAFLD. For time-dependent analyses taking interval censoring into account, we used a pooled logistic regression model to relate time-varying HBV and covariate status measured at each visit to the development of NAFLD. The pooled logistic model closely approximates a Cox model when the risk of outcome between intervals is low. (21) Statistical models were initially adjusted for age and sex and then for BMI, year of screening exam, smoking status, alcohol intake, regular exercise, and education level. We assessed the proportional hazards assumption by examining graphs of estimated log (-log) survival.
We also performed longitudinal linear mixed effects models in order to examine the longitudinal effects of HBV infection on changes in HOMA-IR and lipids from baseline until either the development of fatty liver or the last health exam. In addition, we performed stratified analyses in prespecified subgroups defined by age (<40 versus 40 years), sex (men versus women), smoking (current smoker versus noncurrent smoker), alcohol intake (<10 g/day versus 10 g /day), vigorous exercise (<3 times/week versus 3 times/week), BMI (<25 kg/ m 2 versus 25 kg/m 2 ), HOMA-IR (<2.5 versus 2.5), and ALT levels (<36 U/L versus 36 U/L). Interactions by subgroup characteristics were tested using likelihood ratio tests comparing models with and without multiplicative interaction terms. Statistical analyses were performed using STATA version 14.0 (StataCorp LP, College Station, TX). All P values were two-tailed, and P < 0.05 was considered statistically significant.
Results
At baseline, 3,926 (4.71%) of 83,339 participants were positive for HBsAg ( Table 1) . The mean (standard deviation) age and BMI of the study population were 37.3 years (7.5) and 22.4 kg/m 2 (2.6), respectively. The presence of HBsAg persisted in 95.4% of participants during the follow-up period. Compared to healthy controls, HBsAg-positive subjects were more likely to be male and older. HBsAg positivity was positively associated with obesity and higher levels of highsensitivity C-reactive protein and hepatic enzyme, whereas HBsAg positivity was negatively associated with alcohol intake and triglycerides.
During 484,736.1 person-years of follow-up, 20,200 participants developed NAFLD (incident rate 41.7 per 1,000 person-years) ( Table 2 ). The median follow-up period for participants was 6.6 years (interquartile range 3.0-9.4), and the median follow-up per participant was 5 times (interquartile range 3-8). HBsAg-positive subjects had a lower incidence of NAFLD. In models adjusted for age, sex, year of visit, smoking status, alcohol intake, regular exercise, education level, and BMI, the aHR (95% CI) of incident NAFLD comparing participants with positive HBsAg to those with negative HBsAg was 0.73 (0.69-0.78). The association was virtually unchanged after adjustment for triglycerides, LDL-C, HDL-C, HOMA-IR, and ALT (aHR 5 0.73, 95% CI 0.68-0.78). After introducing HBV infection and confounders (including HOMA-IR and metabolic factors) as timedependent exposures, the association between HBV infection and decreased risk of incident NAFLD was attenuated compared to the model that did not include updated covariates as time-dependent variables. However, the association between HBV infection and incident NAFLD persisted, indicating that the association is partially mediated by metabolic parameters but not fully explained by baseline and updated confounders.
In the mixed model, increases in HOMA-IR levels over time did not differ between HBsAg-positive and HBsAg-negative subjects. On the other hand, the total cholesterol level increased over time among HBsAgnegative subjects, whereas it decreased over time among HBsAg-positive subjects (both P for interactions <0.001; data not shown).
In subgroup analyses (Table 3) , the association between HBsAg and incident NAFLD was consistently observed across prespecified subgroups by age (<40 versus 40 years), sex (men versus women), smoking (current smoker versus noncurrent smoker), alcohol intake (<10 g/day versus 10 g/day), vigorous exercise (<3 times/week versus 3 times/week), BMI (<25 kg/m 2 versus 25 kg/m 2 ), HOMA-IR (<2.5 versus 2.5), and ALT level (<36 U/L versus 36 U/L). However, the association between HBsAg and incident NAFLD was stronger in men (versus women), those with HOMA-IR 2.5 (versus those Table S2 ).
Over follow-up, 144 (0.2% of the cohort) developed cirrhosis. After the exclusion of incident cirrhosis, HBV infection was still significantly associated with lower risk of incident NAFLD, with a corresponding odds ratios of 0.83 (95% CI 0.73-0.94).
Discussion
In this large sample of apparently healthy Korean men and women, HBV infection was significantly associated with a lower risk of incident NAFLD. The *Estimated from parametric Cox models. Multivariable model 1 was adjusted for age, sex, BMI, year of screening exam, smoking status, alcohol intake, regular exercise, and education level; model 2: model 1 plus adjustment for triglycerides, LDL-C, HDL-C, HOMA-IR, and ALT. † Estimated from pooled logistic regression models with HBsAg as a time-dependent variable adjusted for baseline age and sex, with smoking status, alcohol intake, regular exercise, education level, triglycerides, LDL-C, HDL-C, and HOMA-IR as time-dependent variables. Abbreviations: CI, confidence interval; HR, hazard ratio. Hazard ratios (95% confidence intervals) were estimated from parametric Cox models. Multivariable model was adjusted for age, sex, BMI, year of screening exam, smoking status, alcohol intake, regular exercise, and education level.
association remained significant even after adjustment for possible confounders and metabolic factors. To our knowledge, this is the first cohort study to demonstrate an inverse association between HBV infection and development of NAFLD. Previous studies have investigated an association between HBV infection and NAFLD, with conflicting results. Several studies reported that the prevalence of fatty liver determined using ultrasound was comparable between HBV-infected patients and healthy controls. (22, 23) A meta-analysis of 17 studies published until 2010 including 4,100 HBV-infected patients while focusing on comparison between HBV-infected and HCV-infected patients showed a lower prevalence of hepatic steatosis in HBV-infected patients than in HCV-infected patients. (24) Interestingly, the same study demonstrated a strong negative association between HBV DNA and hepatic steatosis in HBVinfected patients, suggesting that HBV may play a protective effect on the development of fatty liver. (22, 24) A recent cross-sectional study using proton-magnetic resonance spectroscopy to define the status of fatty liver found that chronic HBV infection was significantly associated with a lower risk of fatty liver. (12) A largescale study of 22,439 health checkup examinees from Taiwan also demonstrated an inverse association between HBV infection and fatty liver disease. (11) However, all previous studies were confined to a crosssectional design. This large-scale cohort study of 75,619 participants demonstrated that HBV infection is associated with a lower risk of development of NAFLD. The inverse association between HBV infection and incident NAFLD persisted even after adjustment for possible confounders and metabolic factors, indicating that HBV may play an independent and protective role in the development of NAFLD.
The mechanism whereby HBV influences steatosis is not well understood. Studies have suggested an inverse association between HBV infection and lipid profile including cholesterol, triglycerides, HDL-C, and LDL-C. (25) (26) (27) Furthermore, HBV infection has been associated with alterations in lipid metabolism, (28) (29) (30) (31) possibly affecting the development of fatty liver. In the mixed model of our study, the total cholesterol level significantly decreased over time among HBsAg-positive subjects in contrast to its increases among HBsAg-negative subjects. In time-dependent analyses including updated time-varying lipid profiles, the inverse association between HBsAg positivity and incident NAFLD was attenuated but persisted, suggesting that the association is partially mediated but not fully explained by these baseline and updated lipid profiles.
In a previous study, HBV-infected individuals had significantly higher serum adiponectin levels than healthy counterparts, even though chronic HBVinfected individuals were heavier than healthy controls. (32) In the same study, adiponectin level was positively associated with HBV viral load in overweight to obese HBV-infected subjects. Adiponectin, a protein produced by adipose tissue, decreases hepatic and systemic insulin resistance, a key pathogenetic factor in NAFLD. (33, 34) In our study, a significant association between HBsAg seropositivity and incident NAFLD remained even after adjusting for BMI and HOMA-IR; however, adiponectin level was not available. Additional research is needed to better understand the mechanisms involved in the development of NAFLD in HBV patients.
In the subgroup analysis of this study, in patients with raised ALT level, which can reflect hepatocyte damage due to immune response against HBV, (18, 35) the association between HBsAg seropositivity and incident NAFLD was more evident, even though the association was consistently observed in both those with and those without raised ALT levels. The natural course of chronic HBV infection includes immune tolerance, immune clearance, and residual or inactive phase with different immunologic and virological features; and the role of HBV infection in the pathogenesis of steatosis may vary in different phases. Therefore, establishing that HBV infection may affect the development of NAFLD differently by the phase will require additional studies that assess HBV DNA, hepatitis B e antigen, and antibody to HBeAg.
Our study had several limitations. First, we used HBsAg positivity at baseline as an indicator of HBV infection, whereas a repeated measurement of HBsAg after 6 months is needed to confirm chronic HBV infection. However, the presence of HBsAg persisted in 96.9% of participants at the second visit. After excluding those with seroconversion to HBsAg loss, the result was similar. Second, fatty liver was diagnosed using ultrasonography and was not confirmed by histology as this technique is invasive and unfeasible in large population-based epidemiological studies. (36, 37) However, steatosis can be diagnosed with high accuracy by abdominal ultrasound, (38) and many populationbased studies have used ultrasound examination for NAFLD diagnosis. (36) Third, information on antiviral treatment was not available, a fact that could have affected the development of NAFLD. Fourth, hepatitis D virus coinfection was not evaluated in the study population. However, the prevalence of hepatitis D virus coinfection is estimated to be <1% of Korean patients with chronic HBV infection; therefore, this proportion may not affect the overall findings. (39) Fifth, smoking, alcohol use, physical activity, and medical history were assessed with a self-administered structured questionnaire used in health checkup programs in Korea as a part of the National Health Insurance Program, and the measurement errors may have resulted in some degree of residual confounding. (13) Finally, our findings in healthy Korean men and women from an HBV-endemic area might not be generalizable to other populations. Despite the limitations, the considerable strengths of our study include its large sample size as well as the use of carefully standardized clinical, imaging, and laboratory procedures.
In conclusion, hepatitis B infection appears to be associated with lower rates of NAFLD in this Korean population, potentially due to the effects of hepatitis B on lipid metabolism and other as yet undetermined factors.
